ZTEKFOTCMiscellaneous Chemical ProductsUS GAAP · USD

Zentek Ltd.

Zentek Ltd. is a materials and technology company focused on graphene-based products and advanced materials, including ZenGUARD™ air filtration technology and its Albany Graphite project in Northern Ontario. The company operates through a mix of intellectual property development, partner-led commercialization, and mineral resource development activities, with operations centered in Canada and a U.S. subsidiary structure.

Business

Share of revenue
ZenGUARD™ air filtration products30 %

Graphene-based air filter products designed to improve indoor air quality and reduce pressure drop.

Coated media supply15 %

Pre-coated filter media sold to partners for assembly into finished HVAC filters or masks.

Technology licensing35 %

Licensing and technology transfer arrangements for partner commercialization of Zentek IP.

Graphite project development15 %

Development of the Albany Graphite project and related technical and permitting work.

Advanced materials and R&D5 %

Research, validation, and patent-backed development of graphene-based and adjacent materials.

Customers

Zentek sells to commercial partners, manufacturers, and potentially end users rather than a broad consumer base. In air filtration, buyers include HVAC and filter manufacturers, distributors, and institutional customers that need improved indoor air quality solutions. For the graphite and advanced materials platform, the economic buyers are industrial and technology partners that value patented material performance and supply reliability.

HVAC filter manufacturers

They buy coated media or finished ZenGUARD-enhanced products to add air-quality performance to their own filter lines.

Commercial and institutional buildings

They are the end-market users of enhanced filtration where energy efficiency and indoor air quality both matter.

Technology and industrial partners

They license Zentek IP or collaborate on commercialization, manufacturing, and market access.

Graphite and advanced materials developers

They engage with the Albany Graphite asset and related material development capabilities.

Strategy

Zentek's strategy centers on monetizing patented graphene-based technology through licensing, technology transfer, and supply partnerships rather than building a heavy direct manufacturing footprint. The company is also advancing the Albany Graphite asset as a strategic materials platform while building regulatory and commercial pathways for ZenGUARD in priority markets. These priorities reflect a focus on scalable commercialization, intellectual property protection, and partner-enabled market entry.

Partner-led commercializationShort term

Licensing and supply partnerships allow broader market reach with limited capital intensity.

Regulatory pathway executionShort term

Air filtration products require approvals and registrations before market expansion.

IP portfolio expansionMedium term

Patent protection supports monetization, partner negotiations, and geographic expansion.

Albany Graphite developmentMedium term

The graphite asset provides a second strategic platform beyond filtration technologies.

Geography

Zentek is anchored in Canada, with headquarters and core operations in Guelph, Ontario and its Albany Graphite project in Northern Ontario. The company also uses U.S.-based subsidiaries and partners for commercialization, manufacturing, and market entry, especially in the air filtration business. Its business model is shaped by regulatory and partner readiness in both Canada and the United States.

Risks

Zentek's commercialization depends on regulatory approvals, partner execution, and adoption of new filtration technologies, which can delay or limit revenue conversion. The company also faces development risk in its graphite asset and the typical risks of a small, innovation-driven materials company, including scale-up, IP enforcement, and reliance on a narrow product set. Listing and market-structure events are secondary to the business but can affect trading access and investor perception.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Regulatory clearance risk1Partner dependency2Project development risk3Commercial adoption risk4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Regulatory clearance riskImpact: HighLikelihood: High

    ZenGUARD commercialization depends on approvals such as EPA registration and other market-specific requirements.

    Exposure: U.S. air filtration market entry

  2. Partner dependencyImpact: HighLikelihood: Medium

    The licensing and supply model relies on third parties for manufacturing, distribution, and market access.

    Exposure: Quality Filters Inc. and other partners

  3. Project development riskImpact: HighLikelihood: Medium

    Albany Graphite remains a development-stage asset subject to technical, permitting, and funding risk.

    Exposure: Northern Ontario graphite project

  4. Commercial adoption riskImpact: MediumLikelihood: Medium

    Customers may not adopt enhanced filters if performance, pricing, or energy savings are not compelling.

    Exposure: HVAC and institutional filtration markets

Accounting

Judgemental items
Inventory valuation

Raw materials and coated media must be carried at the lower of cost and net realizable value.

Impact: Write-downs could affect margins and asset values if commercialization is delayed.

Expected credit loss allowance

Receivables require estimation of collectability from partners and customers.

Impact: Provision changes can affect earnings when partner payments slow or default risk rises.

Revenue recognition timing

Licensing, supply, and partner-led arrangements may recognize revenue at different points in the contract cycle.

Impact: Quarterly results may be volatile depending on contract milestones and shipments.

IFRS 18 presentation

The standard will change subtotals, aggregation, and performance measure disclosure.

Impact: Comparability across periods and peers may change, even if underlying economics do not.

Publicly listed companies with a comparable business focus.

Last updated: 28/09/2026

Zentek Ltd. (OTC) – Miscellaneous Chemical Products | Financial Analysis – Clarifo